Selling Beats Buying

Happy Prime Day to all. Shop for stuff but don't forget to save some money for renewing your subscription when my site goes properly live again.

As for Tuesdays, it seems that the second weekday is often when selling beats buying in US markets. I think it may be related to the old adage: “Monday's child is fair of face; Tuesday's child is full of grace”. That may imply a graceful exit. The anti-mask brigade wanted to kidnap more governors, putting Trump on the spot over extremism.

Today is definitely a mixed market one with various negatives offsetting surprisingly good results from Dow Jones companies. After JP Morgan-Chase JPM beat on earnings, CEO Jamie Dimon warned that in a worst-case the bank would require another $20 bn in reserves. Johnson & Johnson also beat on sales and earnings thanks to its medical devices business, but then paused its corona-virus clinical trial because of a participant's unexplained illness.

There is a second way that stocks are undermined as well. Analysts hedge their bets by simultaneously raising target prices while lowering the rating of stocks they cover. Here are two examples from today:

Deutsche Bank raised the target price of Autoliv (ALV, sold) by $20 to $85 while cutting it to neutral from positive.

Citigroup put a sell on Tesla but upped its target price to $117 from $110 after the carmaker cut the price of its Model S sedan by 4%. There is another case among the shares we own discussed below.

Hong Kong was hit by revelations that it has coronavirus infections among people with no symptoms whose contacts cannot be traced. There is no joy in foreign lands that are having problems just like the US, but at least don't have a Trump as President.

The International Monetary Fund forecast that the impact of continued social distancing will hurt global economies until the end of 2022, with national debt rising to 125% of gross national product in developed countries and 65% of GNP in emerging markets. This is better than the June forecast.

More for paid subscribers.

*French ute Veolia buying control of archrival Suez by taking over Engie, its 29.9% holder, must fight French courts blocking the takeover. This is scary for anyone who has dealt with a court, to say nothing of a French one. The Paris court blockage of the Engie buy was called “grotesque by VEOEY. I sued 60 Minutes in Paris for firing me for refusing to go to Italy when my daughter was hospitalized and my husband in Iran. A fellow Bronx Science grad who was a French lawyer helped.

Tech

*Our Veoneer VNE scored tops in the European self-driving ranks in Munich last week thanks to its system for the Mercedes GLE winner. As a result, it was cut to hold from overweight by Deutsche Bank but with a higher target price, but recommended outright by Handelsbanken. It is designated supplier of sensors, radar, and stereo cameras for Japan's Subaru. It is partnering without Qualcomm for general driver assistance. We got into QCOM to own an Israeli digital doctoring site held by its start-up sub, which is mostly in Israeli tech. VNE hit a year's high at $18.62 today while. QCOM gained 0.35%.

*While JNJ beat thanks to medical testing devices but lost because of its trials, our own medical test outfit Thermo-Fisher Scientific, TMO. It is my largest holding but a US firm that does not make medicines. It rose 0.5%.

*While Mercado Libre doesn't run a Prime Day MELI is up 3.8%.

*Royal Bank of Canada kept Microsoft MSFT an outperform with a TP of $250, up $20 and it gained 1%.

Energy and environment

*After Hurricane Delta, oil and gas firms moved back into the Gulf of Mexico and prices fell more.

*After its drop Monday Canada Solar, CSIQ, rose 4.46 % today back in the black.

*Chinese car sales last month rose to 2.6 mn vehicles over Sept. 2019 and 11.6% from over August. While we have no breakout figures for NIO sales, its cars should have sold well.

*Azure Power, AZRE, solar supplier to India, gained 4.2% today.

*Japanese robotics maker Fanuc FANUY rose 3% today but is still under our basis.

*Israeli chip maker Tower Semiconductor is up 9.94% and near our basis. TSEM.

*African telephone and ad sell MultiChoice, MCHOY, spun off by Naspers NPSNY rose 0.5%.

*Japanese NTT Docomo stopped falling and rose 0.2% today. DCMYY is being bought back.

Latins and Canadians

*Astra-Zeneca, Pfizer, and China's CanSino will supply Mexico with covid-19 vaccines via an advancer a purchase. AZN is the largest supplier of 39 mn doses, PFE with 17 mn, and Cansino with 35 mn. The govt is diversifying because nobody knows which vaccine will be first or most effective.

*Orbia Advance Corp is up 9% today at $3.27, the highest since the virus hit. MXCHY makes drip feed systems and is our top performer today. It is very volatile.

*Fibra Uno the Mexican REIT, FBASF, is up 0.63%. More funds below.

*Brazilian Cosan which produces sugar and logistics after reporting crashed 2.6% in US trading today. We got out of CZZ in time.

*Kirkland Gold KL Q3 production rose 37% to 339,584 oz and it upped its dividend by 50% so natch the gold miner's shares fell 3.5%.

Pharma

*Eisai ESALY of Japan crashed 4.12% and is our worst performer today. It is an Alzheimer play. We are ahead 29% from our basis.

*While nothing can top MXCHF, Israeli Compugen CGEN is back in the plus column, up 3.15%.

*Martin Ferera's Zymeworks ZYME is up 2%.

Funds

*Japan Small Cap (JOF) is up 1.15% on currency factors.

*Korea Fund, KF, is up 0.6% for the same reason.

*Swiss Helvetia Fund SWZ is up 0.2% to $8.29 for the same reason.

*However income funds are trending down along with New Ireland Fund, IRL, off 1.63%.

*Holding a lot of Nasdaq stock, Investor A/B IVSBF of Sweden is down 1.7% today.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
William K. 3 years ago Member's comment

Quite a collection of information. Thanks for presenting it in an educational manner.

It seems that things are looking up again, at least for a while.

There is now a question as to "how safe" do the computer driven cars actually have to be? This will ultimately have a major effect if it ever becomes widely asked. Values of many stocks may suffer when the answer arrives.

This becomes a "Big Deal" issue because despite the alleged carnage cited by the touts, MOST drivers never are involved in accidents at all. So why pay 35% more for a vehicle that offers NO BENEFIT to most drivers?? At some point it will become obvious that the much better solution is to shift those poor performers over to public transportation and leave the driving to those who do it safely.

Of course, that produces far less income and profit, but the result is inevitable. But it may take a while to become obvious to the right people.